PFM Health Sciences’s Pardes Biosciences, Inc. Common Stock PRDS Stock Holding History

PFM Health Sciences’s Portfolio PRDS Stock Details PRDS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-285,170	Closed	-$528K	–	103
2022 Q3	$528K	Sell	285,170 -516,034	-64%	-$1.54M	0.02%	85
2022 Q2	$2.46M	Buy	801,204 +70,847	+10%	+$433K	0.09%	79
2022 Q1	$5.27M	Buy	730,357 +368,829	+102%	+$3.63M	0.2%	61
2021 Q4	$5.92M	Sell	361,528 -638,472	-64%	-$7.43M	0.2%	62
2021 Q3	$10M	Hold	1,000,000	–	–	0.29%	63
2021 Q2	$10M	Hold	1,000,000	–	–	0.31%	63
2021 Q1	$10M	Buy	+1,000,000	New	+$10.3M	0.3%	65

Other funds holding PRDS

Foresite Capital Management V Larkspur, California $362M AUM 386.37% 1-Year Est. Return

VK Services Menlo Park, California $1.01M AUM 157.81% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Platinum Investment Management Sydney Australia 2000, Australia $407M AUM 87.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Arena Capital Advisors Los Angeles, California $200M AUM 6.35% 1-Year Est. Return

PFM Health Sciences's PRDS Position: Q4 2022 in Review

PFM Health Sciences sold out of Pardes Biosciences, Inc. Common Stock (PRDS) in Q4 2022, closing a stake of 285,170 shares — an estimated $528K sold.

PFM Health Sciences first reported a position in PRDS in Q1 2021 and held it in 7 quarters. The position peaked at $10M in Q2 2021. 65 funds tracked by Wall St. Rank hold PRDS as of Q4 2022.

PFM Health Sciences reported no remaining Pardes Biosciences, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
PFM Health Sciences sold 285,170 Pardes Biosciences, Inc. Common Stock shares in Q4 2022, an estimated $528K.
PFM Health Sciences first reported a position in Pardes Biosciences, Inc. Common Stock in Q1 2021 and held it in 7 quarters.
PFM Health Sciences's Pardes Biosciences, Inc. Common Stock position peaked at $10M in Q2 2021.
65 funds tracked by Wall St. Rank held Pardes Biosciences, Inc. Common Stock as of Q4 2022.

Based on PFM Health Sciences's 13F filing for Q4 2022, filed 14 Feb 2023.